{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "8227865",
  "DateCompleted": {
    "Year": "1993",
    "Month": "12",
    "Day": "16"
  },
  "DateRevised": {
    "Year": "2019",
    "Month": "07",
    "Day": "23"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0091-6749",
      "JournalIssue": {
        "Volume": "92",
        "Issue": "5",
        "PubDate": {
          "Year": "1993",
          "Month": "Nov"
        }
      },
      "Title": "The Journal of allergy and clinical immunology",
      "ISOAbbreviation": "J Allergy Clin Immunol"
    },
    "ArticleTitle": "Effect of rhinovirus 39 infection on cellular immune parameters in allergic and nonallergic subjects.",
    "Pagination": {
      "StartPage": "732",
      "EndPage": "743",
      "MedlinePgn": "732-43"
    },
    "Abstract": {
      "AbstractText": [
        "Patients with allergic rhinitis (AR), compared with nonallergic persons, have been reported to respond differently to a variety of stimuli, some of which are immunologic in nature. This study compared the systemic cellular immune responses to experimental rhinovirus (RV) 39 challenge in RV-39-seronegative AR (n = 20) and nonallergic (n = 18) subjects. Peripheral blood was obtained before, 4 or 7 days after, and 23 days after RV-39 intranasal challenge and assayed for the number and function of various white blood cells. All subjects were infected, as manifested by viral shedding in nasal secretions or seroconversion. RV-39 induced marked changes from baseline values in both immune cell number and functions. Compared with nonallergic subjects, AR subjects manifested different responses for the following parameters: (1) numbers of total white blood cells and lymphocytes (smaller increases on day 4), (2) helper/suppressor T cell ratio (absence of an increase on day 7 and presence of an increase on day 23), (3) number of IL-2 receptor-positive suppressor T cells (presence of a decrease on day 7), (4) natural killer (NK) cell numbers (absence of an increase on day 4 and presence of increases on days 7 and 23), (5) NK/T cell ratio (absence of an increase on day 4 and a decrease on day 7), (6) NK cell activity (a blunted decrease on day 7 and absence of a decrease on day 23), and (7) RV-39-induced lymphocyte proliferation (exaggerated increase on day 4). The results show that intranasal challenge with RV-39 induced RV-39-specific and nonspecific systemic cellular immune responses and a unique immunologic response pattern in AR subjects."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Pediatrics, University of Pittsburgh, PA."
          }
        ],
        "LastName": "Skoner",
        "ForeName": "D P",
        "Initials": "DP"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Whiteside",
        "ForeName": "T L",
        "Initials": "TL"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Wilson",
        "ForeName": "J W",
        "Initials": "JW"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Doyle",
        "ForeName": "W J",
        "Initials": "WJ"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Herberman",
        "ForeName": "R B",
        "Initials": "RB"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Fireman",
        "ForeName": "P",
        "Initials": "P"
      }
    ],
    "GrantList": [
      {
        "GrantID": "AI19262",
        "Acronym": "AI",
        "Agency": "NIAID NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "MO1RR00084",
        "Acronym": "RR",
        "Agency": "NCRR NIH HHS",
        "Country": "United States"
      }
    ],
    "PublicationTypeList": [
      "Comparative Study",
      "Journal Article",
      "Research Support, Non-U.S. Gov't",
      "Research Support, U.S. Gov't, P.H.S."
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "J Allergy Clin Immunol",
    "NlmUniqueID": "1275002",
    "ISSNLinking": "0091-6749"
  },
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Adult"
    },
    {
      "QualifierName": [],
      "DescriptorName": "CD4-CD8 Ratio"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Child"
    },
    {
      "QualifierName": [
        "immunology",
        "physiopathology"
      ],
      "DescriptorName": "Common Cold"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Immunity, Cellular"
    },
    {
      "QualifierName": [
        "cytology"
      ],
      "DescriptorName": "Killer Cells, Natural"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Leukocyte Count"
    },
    {
      "QualifierName": [
        "immunology"
      ],
      "DescriptorName": "Leukocytes"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Lymphocyte Activation"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [
        "physiology"
      ],
      "DescriptorName": "Nasal Mucosa"
    },
    {
      "QualifierName": [
        "immunology"
      ],
      "DescriptorName": "Respiratory Hypersensitivity"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Rhinovirus"
    }
  ]
}